Pauline Irungu is the director policy and public affairs at Pfizer. She previously worked as the Global Policy and Advocacy Advisor at PATH where she led PATH’s advocacy for prioritization, financing, and equitable access to quality maternal, newborn and child health. She is a policy and advocacy leader with two decades’ experience engaging global organizations and governments in the African region advocating for stronger policies and investments in women’s and children’s health and global health research and development. She has extensive experience ensuring that civil society is a driving voice behind government decision-making and policy actions. In her previous role, she built strategic and collaborative relations with civil society in East Africa to influence regional policy and investment priorities for health and was a thought partner to the Kenyan government around health policy-making.
Ms. Irungu has collaborated with the African Union Development Agency to bring the voice of civil society into policies and initiatives for medicines regulation in Africa and continues to be a member of the Africa Medicines Regulatory Harmonization Partnership Platform. From 2019 to 2021, she served as a civil society representative to the Global Financing Facility for Women, Children, and Adolescents (GFF) Investors Group. Currently, she is the global co-chair of the Accountability Working Group and a member of the NGOs Constituency Leadership Group of the Partnership for Maternal, Newborn and Child Health (PMNCH). Ms. Irungu earned a post-graduate certificate in public health from the University of Roehampton and a Bachelor of Science in Information Sciences from Moi University.
